Status:
COMPLETED
The Effect of Combined Hydrodilatation, Corticosteroid Injection, and Joint Mobilization for Treament of Frozen Shoulder
Lead Sponsor:
Shin Kong Wu Ho-Su Memorial Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Frozen Shoulder
Hydrodilatation
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
The effect of combination of hydrodilatation, corticosteroid injection, and joint mobilization for treatment of frozen shoulder, compared with general physical therapy.
Detailed Description
Frozen shoulder (FS) is a common clinical problem which induces pain, loss of passive and active range of motion (ROM) of glenohumeral joint, and leads to disability, functional limitation, and decrea...
Eligibility Criteria
Inclusion
- . age between 20 to 80 years old;
- . chronic shoulder pain for ≥ 3 months;
- . \> 30% loss of passive range of motion (ROM) of the affected shoulder in either external rotation or abduction, comparing with the sound side;
- . visual analog scale for pain on maximal passive external rotation or abduction \> 4.
Exclusion
- . Severe systemic disorders including cancer, stroke, or cardiopulmonary diseases;
- . Uncontrolled DM;
- . Rotator cuff tear or calcification of the affected shoulder;
- . Fracture, dislocation, or arthritis of the shoulder due to rheumatic disorders;
- . a history of drug allergy to local anesthetics or corticosteroids;
- . receiving corticosteroid or hyaluronic acid joint or bursa injection of the affected shoulder during the preceding three months.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04474145
Start Date
August 1 2020
End Date
July 31 2022
Last Update
October 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan